Carbon Dots Fabrication: Ocular Imaging and Therapeutic Potential

Area of Science:

• Ophthalmic drug delivery
• Biomedical engineering
• Nanomedicine

Background:

• Ocular infections and diseases like bacterial keratitis, age-related macular degeneration (AMD), and diabetic retinopathy (DR) cause significant vision loss.
• Current ophthalmic treatments have limitations and safety concerns, necessitating novel drug delivery systems.
• Carbon dots (CDs), derived from natural polymers, are biocompatible, environmentally friendly, and possess tunable fluorescence.

Purpose of the Study:

• To explore the potential of carbon dots (CDs) for developing advanced, long-term therapies for ophthalmic diseases.
• To review the fabrication of CDs and their application in targeted drug delivery and bio-imaging for eye conditions.
• To highlight the advantages of CDs over inorganic nanomaterials for ophthalmic drug delivery.

Main Methods:

• Review of existing literature on carbon dot synthesis and their biomedical applications.
• Analysis of CD properties relevant to ophthalmic drug delivery, including fluorescence and biocompatibility.
• Exploration of CD conjugation with anti-bacterial agents and anti-VEGF molecules for ophthalmic use.

Main Results:

• Carbon dots demonstrate tunable fluorescence, excellent biocompatibility, and capacity for conjugation with therapeutic agents.
• CDs offer a promising alternative to toxic inorganic nanomaterials for drug delivery in ocular applications.
• Potential applications include targeted delivery of anti-bacterial agents, anti-VEGF molecules, and enhanced bio-imaging for ophthalmic diseases.

Conclusions:

• Carbon dots represent a significant advancement in ophthalmic drug delivery, offering enhanced safety and efficacy.
• Further research into CD fabrication and functionalization can lead to innovative translational therapies for vision-threatening eye diseases.
• CDs hold great promise for improving treatment outcomes and diagnostic capabilities in ophthalmology.